Zimmer rated at outperform by RBC

RBC Capital Markets analyst William R. Quirk rated Zimmer Holdings, Inc. at outperform, above average risk on news of the company's second-quarter constant currency revenue growth of 5.3% to $881.6 million, slightly above RBC's lowered estimate of $880.0 million and below Street consensus of $889.3 million). Hip and knee growth rates were disappointing, up 3% and 5% in constant currency, according to the analyst. Expected new product launches could help both segments during the second half of the year. Shares of the Warsaw, Ind.-based orthopedic implant products company were up 75 cents, or 1.25%, at $60.60 on volume of 3,444,000 shares versus the three-month running average of 2,471,380 shares. (NYSE: ZMH)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.